Molecular mechanisms for enhanced DNA vaccine immunogenicity
In the two decades since their initial discovery, DNA vaccines technologies have come a long way. Unfortunately, when applied to human subjects inadequate immunogenicity is still the biggest challenge for practical DNA vaccine use. Many different strategies have been tested in preclinical models to...
Saved in:
| Published in | Expert review of vaccines Vol. 15; no. 3; p. 313 |
|---|---|
| Main Authors | , |
| Format | Journal Article |
| Language | English |
| Published |
England
03.03.2016
|
| Subjects | |
| Online Access | Get more information |
| ISSN | 1744-8395 |
| DOI | 10.1586/14760584.2016.1124762 |
Cover
Loading…
| Abstract | In the two decades since their initial discovery, DNA vaccines technologies have come a long way. Unfortunately, when applied to human subjects inadequate immunogenicity is still the biggest challenge for practical DNA vaccine use. Many different strategies have been tested in preclinical models to address this problem, including novel plasmid vectors and codon optimization to enhance antigen expression, new gene transfection systems or electroporation to increase delivery efficiency, protein or live virus vector boosting regimens to maximise immune stimulation, and formulation of DNA vaccines with traditional or molecular adjuvants. Better understanding of the mechanisms of action of DNA vaccines has also enabled better use of the intrinsic host response to DNA to improve vaccine immunogenicity. This review summarizes recent advances in DNA vaccine technologies and related intracellular events and how these might impact on future directions of DNA vaccine development. |
|---|---|
| AbstractList | In the two decades since their initial discovery, DNA vaccines technologies have come a long way. Unfortunately, when applied to human subjects inadequate immunogenicity is still the biggest challenge for practical DNA vaccine use. Many different strategies have been tested in preclinical models to address this problem, including novel plasmid vectors and codon optimization to enhance antigen expression, new gene transfection systems or electroporation to increase delivery efficiency, protein or live virus vector boosting regimens to maximise immune stimulation, and formulation of DNA vaccines with traditional or molecular adjuvants. Better understanding of the mechanisms of action of DNA vaccines has also enabled better use of the intrinsic host response to DNA to improve vaccine immunogenicity. This review summarizes recent advances in DNA vaccine technologies and related intracellular events and how these might impact on future directions of DNA vaccine development. |
| Author | Petrovsky, Nikolai Li, Lei |
| Author_xml | – sequence: 1 givenname: Lei surname: Li fullname: Li, Lei organization: b Department of Diabetes and Endocrinology , Flinders University, Flinders Medical Centre , Adelaide , SA , Australia – sequence: 2 givenname: Nikolai surname: Petrovsky fullname: Petrovsky, Nikolai organization: b Department of Diabetes and Endocrinology , Flinders University, Flinders Medical Centre , Adelaide , SA , Australia |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/26707950$$D View this record in MEDLINE/PubMed |
| BookMark | eNo1j8tKw0AUQAdR7EM_QZkfSLzzvAm4KbU-oOpG12UedzSSTErSCv17C-rqcDYHzoyd5j4TY1cCSmEqeyM0WjCVLiUIWwohjy5P2FSg1kWlajNhs3H8AlC6NnjOJtIiYG1gym6f-5bCvnUD7yh8utyM3chTP3DKRwsU-d3Lgn-7EJpMvOm6fe4_KDeh2R0u2Fly7UiXf5yz9_vV2_KxWL8-PC0X6yJY0LsCk6zRUfQYsfIUo9TBG8BoA6BPpnLKU-3IgRZQo0rgyCiEkIxx1ig5Z9e_3e3edxQ326Hp3HDY_G_IHxhISys |
| CitedBy_id | crossref_primary_10_1111_bcp_15552 crossref_primary_10_1186_s12985_022_01909_9 crossref_primary_10_1016_j_micpath_2020_104553 crossref_primary_10_1016_j_micpath_2020_104435 crossref_primary_10_1080_21645515_2023_2234790 crossref_primary_10_54033_cadpedv21n5_021 crossref_primary_10_1016_S1773_035X_19_30258_8 crossref_primary_10_3390_pharmaceutics15041106 crossref_primary_10_3390_immuno1040031 crossref_primary_10_3390_vaccines12050538 crossref_primary_10_1021_acs_jcim_9b01051 crossref_primary_10_3390_ijms25021076 crossref_primary_10_3390_vaccines12010071 crossref_primary_10_1016_j_vaccine_2020_06_053 crossref_primary_10_3390_vaccines10091560 crossref_primary_10_2174_1381612829666230830105758 crossref_primary_10_3347_PHD_22097 crossref_primary_10_1016_j_drudis_2021_06_008 crossref_primary_10_1016_j_aan_2022_07_002 crossref_primary_10_1016_j_retram_2022_103348 crossref_primary_10_1080_14760584_2021_1887735 crossref_primary_10_3389_fimmu_2023_1252554 crossref_primary_10_1360_SSV_2021_0133 crossref_primary_10_17816_MAJ34092 crossref_primary_10_1007_s11912_021_01130_x crossref_primary_10_3389_fcimb_2022_1016897 crossref_primary_10_1177_11779322251315924 crossref_primary_10_3390_life13071498 crossref_primary_10_1016_j_addr_2020_06_019 crossref_primary_10_3390_ani12223072 crossref_primary_10_1186_s12967_019_1991_3 crossref_primary_10_2174_1871526520666201005141159 crossref_primary_10_1007_s12032_023_02060_3 crossref_primary_10_3389_fmicb_2024_1326369 crossref_primary_10_1051_e3sconf_202130901038 crossref_primary_10_1016_j_cyto_2021_155703 crossref_primary_10_1080_14760584_2021_1987223 crossref_primary_10_1155_japr_1655679 crossref_primary_10_1002_adfm_202211669 crossref_primary_10_1016_j_ajps_2020_08_001 crossref_primary_10_3390_vaccines13010065 crossref_primary_10_1016_j_jhep_2020_02_009 crossref_primary_10_1016_j_psj_2024_103469 crossref_primary_10_1080_21645515_2017_1330236 crossref_primary_10_1016_j_nano_2021_102443 crossref_primary_10_1016_j_intimp_2021_107439 crossref_primary_10_1007_s11095_021_03143_4 crossref_primary_10_3389_fimmu_2020_02130 crossref_primary_10_3389_fimmu_2022_881753 crossref_primary_10_1016_j_addr_2021_01_003 crossref_primary_10_2174_1568026623666230825094341 crossref_primary_10_17826_cumj_1394329 crossref_primary_10_3389_fimmu_2024_1475886 crossref_primary_10_1007_s13205_019_1804_7 crossref_primary_10_3389_fvets_2023_1243835 crossref_primary_10_1016_j_csbj_2021_04_061 crossref_primary_10_3390_ijms24087013 crossref_primary_10_3389_fmicb_2022_927031 crossref_primary_10_1080_08923973_2018_1498099 crossref_primary_10_1016_j_molimm_2021_09_002 crossref_primary_10_1007_s00705_020_04777_2 crossref_primary_10_1016_j_vaccine_2017_11_047 crossref_primary_10_1002_adtp_201900154 crossref_primary_10_3389_fcell_2021_781768 crossref_primary_10_1016_j_jconrel_2019_10_045 crossref_primary_10_1080_21645515_2019_1593729 crossref_primary_10_1016_j_vaccine_2020_09_062 crossref_primary_10_3390_v14030591 crossref_primary_10_3389_fimmu_2024_1498431 crossref_primary_10_1016_j_actbio_2018_08_033 crossref_primary_10_3748_wjg_v27_i41_7005 crossref_primary_10_1158_1535_7163_MCT_18_0832 crossref_primary_10_1007_s00253_022_11812_6 crossref_primary_10_1016_j_vacun_2023_08_002 crossref_primary_10_3389_fimmu_2017_01989 crossref_primary_10_1177_11769351221150772 crossref_primary_10_1016_j_virs_2024_05_005 crossref_primary_10_3892_ol_2021_12916 crossref_primary_10_1080_14760584_2023_2292772 crossref_primary_10_3389_fimmu_2024_1433185 crossref_primary_10_1080_21505594_2024_2345019 crossref_primary_10_1002_adhm_202300339 crossref_primary_10_3389_fcell_2021_633776 crossref_primary_10_1016_j_jmb_2023_168297 crossref_primary_10_1080_21645515_2021_1911204 crossref_primary_10_1007_s00109_019_01844_3 crossref_primary_10_3389_fimmu_2023_1234912 crossref_primary_10_3390_v15081694 crossref_primary_10_3389_fimmu_2021_726615 crossref_primary_10_1080_14760584_2023_2157818 crossref_primary_10_3390_vaccines12050478 crossref_primary_10_1016_j_drudis_2020_09_005 crossref_primary_10_3389_fcimb_2022_909223 crossref_primary_10_3390_vaccines13020151 crossref_primary_10_3347_kjp_2018_56_3_237 crossref_primary_10_1007_s00262_018_2185_1 crossref_primary_10_1002_adhm_202001812 crossref_primary_10_3390_nano13172455 crossref_primary_10_1016_j_smim_2020_101430 crossref_primary_10_3390_ijms21062234 crossref_primary_10_1080_14760584_2021_1969230 crossref_primary_10_1016_j_fsi_2023_108828 crossref_primary_10_3390_vaccines9060540 crossref_primary_10_1080_21645515_2023_2202127 crossref_primary_10_3390_vaccines8020216 crossref_primary_10_1016_j_lfs_2024_122652 crossref_primary_10_1016_j_omtn_2023_04_029 crossref_primary_10_5937_arhfarm1906385A crossref_primary_10_1016_j_medntd_2021_100091 crossref_primary_10_3892_ijmm_2020_4596 crossref_primary_10_1007_s10529_020_03060_3 crossref_primary_10_1016_j_ymthe_2019_08_007 crossref_primary_10_1002_jgm_3150 crossref_primary_10_1080_14760584_2019_1642110 crossref_primary_10_1155_2020_4297937 crossref_primary_10_3390_cancers14205163 crossref_primary_10_3390_vaccines12121360 crossref_primary_10_1080_14760584_2018_1526085 crossref_primary_10_3390_pharmaceutics14112259 crossref_primary_10_3390_ijms24021011 crossref_primary_10_3390_v16101580 crossref_primary_10_1016_j_cimid_2020_101413 crossref_primary_10_2174_1386207326666221108095705 crossref_primary_10_3390_cancers12051121 crossref_primary_10_17816_MAJ108614 crossref_primary_10_1016_j_smim_2021_101533 crossref_primary_10_1016_j_vaccine_2021_08_103 crossref_primary_10_1186_s40779_021_00360_1 crossref_primary_10_3389_fonc_2021_752444 crossref_primary_10_3389_fendo_2023_1076404 crossref_primary_10_3389_fmedt_2021_782986 crossref_primary_10_1007_s00203_023_03480_5 crossref_primary_10_1016_j_jiph_2020_12_025 crossref_primary_10_1111_jfd_14002 crossref_primary_10_3390_ijms24054969 crossref_primary_10_1080_21645515_2023_2292381 crossref_primary_10_4103_jfmpc_jfmpc_1570_20 crossref_primary_10_3390_biom14040503 crossref_primary_10_1016_j_fuel_2018_08_070 crossref_primary_10_1002_jgm_3092 crossref_primary_10_1099_jgv_0_001746 crossref_primary_10_1007_s12668_024_01676_7 crossref_primary_10_3389_fmedt_2021_640964 crossref_primary_10_1038_s41541_020_00238_8 crossref_primary_10_1002_anbr_202200122 crossref_primary_10_1016_j_tjog_2021_05_020 crossref_primary_10_1111_cas_15044 crossref_primary_10_1016_j_addr_2020_12_008 crossref_primary_10_1016_j_procbio_2022_12_002 crossref_primary_10_1016_j_ijbiomac_2025_140558 crossref_primary_10_1186_s13046_019_1154_7 crossref_primary_10_3390_vaccines10081249 crossref_primary_10_1016_j_bbrc_2021_02_109 crossref_primary_10_2331_suisan_WA2421 crossref_primary_10_1021_acsnano_1c05002 crossref_primary_10_1016_j_lfs_2020_117398 crossref_primary_10_1016_j_ijbiomac_2021_08_076 crossref_primary_10_1186_s40794_022_00176_4 crossref_primary_10_3390_vaccines11020280 crossref_primary_10_1007_s11684_023_1034_6 crossref_primary_10_3390_vaccines9050431 crossref_primary_10_30895_2221_996X_2019_19_2_72_80 crossref_primary_10_1016_j_lfs_2020_118919 crossref_primary_10_3389_fcimb_2021_787635 crossref_primary_10_3390_nano11071788 crossref_primary_10_1016_j_cell_2021_01_017 crossref_primary_10_1038_s41392_022_01270_x crossref_primary_10_1111_1751_7915_70053 crossref_primary_10_1016_j_vaccine_2025_126965 crossref_primary_10_1016_j_drudis_2019_07_011 crossref_primary_10_1016_j_addr_2021_113889 crossref_primary_10_3390_vaccines12020141 crossref_primary_10_1016_j_mattod_2023_04_008 crossref_primary_10_1016_j_lfs_2020_117956 crossref_primary_10_1021_acsami_3c14305 crossref_primary_10_1016_j_vaccine_2021_01_002 crossref_primary_10_3389_fmicb_2022_789882 crossref_primary_10_1016_j_vacune_2024_02_013 crossref_primary_10_1080_17425247_2023_2189697 crossref_primary_10_1021_acsnano_0c07197 crossref_primary_10_1166_jbn_2021_3081 crossref_primary_10_1111_mve_12594 crossref_primary_10_1016_j_micinf_2020_09_004 crossref_primary_10_3389_fimmu_2021_711650 crossref_primary_10_1142_S2529732521400022 crossref_primary_10_1111_sji_12633 crossref_primary_10_1186_s12967_023_04519_3 crossref_primary_10_2139_ssrn_3900407 crossref_primary_10_1039_D0RA06849G crossref_primary_10_1038_s41598_018_26281_z crossref_primary_10_1097_MRM_0000000000000393 crossref_primary_10_14260_jemds_2021_814 crossref_primary_10_3389_fmicb_2021_633946 crossref_primary_10_1016_j_intimp_2017_11_041 crossref_primary_10_1002_biot_202300658 crossref_primary_10_3390_vaccines12080928 crossref_primary_10_1016_j_mcp_2022_101833 crossref_primary_10_1038_s41434_022_00376_9 crossref_primary_10_37349_ei_2021_00024 crossref_primary_10_3390_pharmaceutics14081721 crossref_primary_10_36233_0372_9311_553 crossref_primary_10_3389_fimmu_2018_01568 crossref_primary_10_3390_vaccines12020212 crossref_primary_10_1099_jgv_0_000700 crossref_primary_10_1073_pnas_1814584116 crossref_primary_10_1016_j_bbagen_2021_130019 crossref_primary_10_1016_j_vaccine_2019_11_031 crossref_primary_10_1186_s12985_024_02604_7 crossref_primary_10_1016_j_jddst_2022_103964 crossref_primary_10_1016_j_mam_2023_101224 crossref_primary_10_1186_s12929_024_01102_w crossref_primary_10_3390_life12091326 crossref_primary_10_3390_ph14050406 crossref_primary_10_1159_000514225 crossref_primary_10_3389_fonc_2021_626463 crossref_primary_10_1021_acs_bioconjchem_8b00688 crossref_primary_10_1093_infdis_jiad235 crossref_primary_10_3390_pharmaceutics13020159 crossref_primary_10_1021_acsnano_0c00326 |
| ContentType | Journal Article |
| DBID | CGR CUY CVF ECM EIF NPM |
| DOI | 10.1586/14760584.2016.1124762 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
| DatabaseTitleList | MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Biology |
| EISSN | 1744-8395 |
| ExternalDocumentID | 26707950 |
| Genre | Journal Article Review Research Support, N.I.H., Extramural |
| GrantInformation_xml | – fundername: PHS HHS grantid: HHSN272200800039C – fundername: PHS HHS grantid: HHSN272201400053C – fundername: NIAID NIH HHS grantid: HHSN272201400053C – fundername: NIAID NIH HHS grantid: HHSN272200800039C |
| GroupedDBID | --- 0BK 0VX 0YH 29G 3V. 4.4 53G 5GY 7X7 88E 8AO 8C1 8FI 8FJ AAGSP AAHJP AANCX AAOUU ABEIZ ABJNI ABJXJ ABKMU ABLKL ABUWG ABXYU ACFRI ACGFS ACNPW ADBBV ADCVX AECIN AENEX AEOZL AESAV AFKRA AGDLA AGMLL AHMBA AIJEM AIYSM AKBVH ALIPV ALMA_UNASSIGNED_HOLDINGS ALQZU AN0 BENPR BLEHA BNQBC BPHCQ BVXVI CBZEQ CCCUG CCPQU CGR CS3 CUY CVF DDEWX DGYZD DU5 EBS ECM EIF EJD F5P FYUFA GROUPED_DOAJ H13 HMCUK HZ~ IAO IEA IHR ITC KYCEM LJTGL M1P M4Z MV1 NPM O9- OVD P2P PQQKQ PROAC PSQYO RFE RNANH SJN TBQAZ TCNNB TDBHL TEORI TFL TFW TUROJ UKHRP |
| ID | FETCH-LOGICAL-c604t-7f297aedb7d78bedd24cb507d6c07bf58a3be9aea0410973f0ae5370cf55a6532 |
| IngestDate | Thu Jan 02 22:22:12 EST 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 3 |
| Keywords | DNA vaccine plasmid vaccine delivery molecular adjuvant immunogenicity |
| Language | English |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c604t-7f297aedb7d78bedd24cb507d6c07bf58a3be9aea0410973f0ae5370cf55a6532 |
| OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/4955855 |
| PMID | 26707950 |
| ParticipantIDs | pubmed_primary_26707950 |
| PublicationCentury | 2000 |
| PublicationDate | 2016-03-03 |
| PublicationDateYYYYMMDD | 2016-03-03 |
| PublicationDate_xml | – month: 03 year: 2016 text: 2016-03-03 day: 03 |
| PublicationDecade | 2010 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England |
| PublicationTitle | Expert review of vaccines |
| PublicationTitleAlternate | Expert Rev Vaccines |
| PublicationYear | 2016 |
| References | 24968881 - Oncology. 2014;87(1):21-9 23258413 - Science. 2013 Feb 15;339(6121):786-91 21931737 - PLoS One. 2011;6(9):e24517 24812879 - Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2013 Aug;31(4):284-9 22930438 - J Gene Med. 2012 Sep-Oct;14(9-10):563-9 24788626 - PLoS One. 2014 May 01;9(5):e96609 24648995 - Biomed Rep. 2013 Jul;1(4):609-613 22806099 - Mucosal Immunol. 2013 Jan;6(1):156-66 21573215 - PLoS One. 2011 May 05;6(5):e19407 21544098 - Gene Ther. 2012 Jan;19(1):70-7 23111169 - Hum Vaccin Immunother. 2012 Nov 1;8(11):1654-8 9820537 - J Immunol. 1998 Nov 15;161(10):5594-9 23228812 - Vaccine. 2013 Jan 21;31(5):784-90 24447183 - Clin Microbiol Infect. 2014 May;20 Suppl 5:110-7 20351693 - Nat Immunol. 2010 May;11(5):385-93 23388631 - Proc Natl Acad Sci U S A. 2013 Feb 19;110(8):2969-74 26122168 - Drug Deliv Transl Res. 2015 Aug;5(4):424-37 24316385 - J Theor Biol. 2014 Mar 7;344:19-30 1690918 - Science. 1990 Mar 23;247(4949 Pt 1):1465-8 16525482 - Gene Ther. 2006 Jul;13(14):1110-7 21987727 - Cancer Res. 2011 Dec 15;71(24):7452-62 9712056 - J Immunol. 1998 Aug 15;161(4):1875-82 24828254 - Curr Gene Ther. 2014;14(3):161-9 15652668 - Vaccine. 2005 Jan 26;23(10):1258-64 21772284 - Nat Immunol. 2011 Jul 19;12(8):729-31 22350714 - Parasitol Res. 2012 Jul;111(1):403-11 9013964 - J Immunol. 1997 Feb 1;158(3):1231-7 25270431 - Eur J Immunol. 2015 Jan;45(1):82-8 8399489 - Hum Gene Ther. 1993 Aug;4(4):419-31 15312142 - Immunology. 2004 Sep;113(1):114-20 21106745 - J Virol. 2011 Feb;85(3):1370-83 20583863 - Hum Gene Ther. 2010 Dec;21(12):1687-96 15491818 - J Control Release. 2004 Nov 5;100(1):145-55 25539925 - Nucleic Acids Res. 2015 Mar 11;43(5):e34 23840043 - J Infect Dis. 2013 Sep 1;208(5):818-29 19162111 - Vaccine. 2009 Feb 25;27(9):1306-16 20371391 - Vaccine. 2010 May 21;28(23):3888-95 23036592 - J Neuroimmunol. 2013 Jan 15;254(1-2):63-8 23647843 - Cell. 2013 May 23;153(5):1094-107 10946143 - Vet Microbiol. 2000 Sep 25;76(2):129-42 25070851 - J Immunol. 2014 Sep 1;193(5):2394-404 18256672 - Nature. 2008 Feb 7;451(7179):725-9 18781156 - Nat Rev Genet. 2008 Oct;9(10):776-88 19321146 - Curr Biol. 2009 Mar 24;19(6):R262-5 25746201 - Hum Vaccin Immunother. 2015;11(8):1983-90 23371516 - Pharm Res. 2013 Jun;30(6):1502-12 24573220 - Arch Virol. 2014 Aug;159(8):1951-60 25364509 - Ther Adv Vaccines. 2014 Nov;2(6):159-82 21857901 - PLoS One. 2011;6(8):e21225 24720881 - Biomaterials. 2014 Jul;35(21):5491-504 23227156 - PLoS One. 2012;7(12):e49952 23457473 - PLoS One. 2013;8(2):e55571 25487734 - Expert Rev Vaccines. 2015 Feb;14(2):195-204 20890285 - Nat Immunol. 2010 Nov;11(11):997-1004 15479434 - Immunol Cell Biol. 2004 Oct;82(5):488-96 21975270 - Lancet Infect Dis. 2011 Dec;11(12):916-24 26344618 - Vaccines (Basel). 2014 Mar 25;2(2):196-215 9795388 - Vaccine. 1998 Nov;16(19):1828-35 21743478 - Nat Immunol. 2011 Jul 10;12(8):786-95 22095092 - Cancer Immunol Immunother. 2012 Jun;61(6):893-903 25027602 - Cytokine Growth Factor Rev. 2014 Dec;25(6):649-55 20833440 - Trends Biotechnol. 2010 Nov;28(11):570-9 21815811 - OMICS. 2011 Sep;15(9):533-7 23841051 - Biomed Res Int. 2013;2013:136492 23142775 - Nat Immunol. 2012 Dec;13(12):1155-61 22361816 - Cancer Gene Ther. 2012 May;19(5):303-11 25142448 - Curr Gene Ther. 2014;14(3):170-89 10048771 - J Interferon Cytokine Res. 1999 Jan;19(1):77-84 21157438 - Mol Ther. 2011 Mar;19(3):594-601 24821782 - Proc Natl Acad Sci U S A. 2014 May 27;111(21):7747-52 23196205 - Vaccine. 2013 Jan 11;31(4):676-84 21732819 - OMICS. 2011 Sep;15(9):625-36 16601357 - Intervirology. 2006;49(4):249-52 24932692 - PLoS One. 2014 Jun 16;9(6):e99887 25992460 - J Biomed Nanotechnol. 2014 Sep;10(9):2332-49 23631937 - Virus Res. 2013 Aug;175(2):120-7 17618271 - Nature. 2007 Jul 26;448(7152):501-5 21081900 - Mol Ther. 2011 Mar;19(3):450-60 21765404 - Nat Med. 2011 Jul 17;17 (8):996-1002 1545867 - Nature. 1992 Mar 12;356(6365):152-4 21102455 - Nat Biotechnol. 2010 Dec;28(12):1287-9 21152572 - Mol Biosyst. 2011 Mar;7(3):809-16 22133510 - Vaccine. 2012 Jan 17;30(4):758-66 19237523 - Infect Immun. 2009 May;77(5):2221-9 23746241 - Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2013 Jun;29(6):585-8 11130078 - Nature. 2000 Dec 7;408(6813):740-5 23488597 - J Fish Dis. 2013 Sep;36(9):763-8 24385146 - Gene Ther. 2014 Feb;21(2):225-32 20432465 - J Cell Physiol. 2010 Sep;224(3):702-9 19389445 - Vaccine. 2009 Jun 19;27(30):4010-7 25128840 - Immunol Lett. 2014 Nov;162(1 Pt A):140-8 23709057 - Virol Sin. 2013 Jun;28(3):167-73 24717539 - Nat Commun. 2014 Apr 10;5:3566 24830435 - Gene Ther. 2014 Jul;21(7):703-8 25984993 - Hum Vaccin Immunother. 2015;11(8):1889-900 25192845 - BMC Infect Dis. 2014 Sep 06;14:487 22552442 - Mol Med Rep. 2012 Jul;6(1):139-44 8212843 - Vaccine. 1993;11(9):957-60 23251783 - Elife. 2012 Dec 18;1:e00047 24694539 - Gene Ther. 2014 Jun;21(6):566-74 21325489 - Clin Vaccine Immunol. 2011 Apr;18(4):533-8 18694965 - Infect Immun. 2008 Oct;76(10):4564-73 10501231 - Vaccine. 1999 Aug 20;18(1-2):18-28 11039923 - Science. 2000 Oct 20;290(5491):486-92 24440303 - Int Immunopharmacol. 2014 Mar;19(1):74-80 25104313 - BMC Bioinformatics. 2014;15 Suppl 4:S2 21844392 - J Immunol. 2011 Sep 15;187(6):3391-401 19579009 - Biotechnol Lett. 2009 Nov;31(11):1685-93 24122866 - J Med Virol. 2014 May;86(5):886-94 23459514 - Mol Ther. 2013 May;21(5):954-63 16965361 - FEMS Immunol Med Microbiol. 2006 Oct;48(1):132-9 23270684 - Mol Immunol. 2013 Jun;54(2):109-14 23151452 - Hum Vaccin Immunother. 2012 Nov 1;8(11):1659-67 16490926 - Microbiol Immunol. 2006;50(2):83-92 20483191 - Vaccine. 2010 Jul 19;28(32):5347-55 24284319 - J Virol. 2014 Feb;88(4):1924-34 26121679 - PLoS One. 2015 Jun 29;10(6):e0131748 24884387 - Respir Res. 2014 May 20;15:60 21198665 - Immunol Rev. 2011 Jan;239(1):62-84 19066740 - Immunol Res. 2008;42(1-3):219-32 15068842 - Vaccine. 2004 Apr 16;22(13-14):1609-15 23861017 - Virus Genes. 2013 Oct;47(2):259-67 23774102 - J Control Release. 2013 Sep 28;170(3):452-9 21107439 - Gene Ther. 2011 Apr;18(4):334-43 22240344 - Vaccine. 2012 Feb 21;30(9):1624-35 24448159 - Parasitol Int. 2014 Apr;63(2):408-16 23941509 - BMC Immunol. 2013 Aug 14;14:39 24531764 - Nature. 2014 Mar 27;507(7493):519-22 25488991 - J Immunol. 2015 Jan 15;194(2):630-6 8506285 - Proc Natl Acad Sci U S A. 1993 May 15;90(10):4455-9 12477432 - Vaccine. 2002 Dec 19;20 Suppl 4:A69-79 23776192 - J Infect Dis. 2013 Sep;208(6):1008-19 12390544 - J Med Primatol. 2002 Aug;31(4-5):217-27 24631071 - Vaccine. 2014 Apr 25;32(20):2308-14 16226783 - Virology. 2006 Jan 20;344(2):412-20 25410055 - Eur J Immunol. 2015 Feb;45(2):624-35 21371510 - J Control Release. 2011 Jun 30;152(3):349-55 25265876 - Med Microbiol Immunol. 2015 Aug;204(4):481-91 16179799 - J Mol Microbiol Biotechnol. 2004;8(4):222-31 21169215 - J Gen Virol. 2011 Jan;92(Pt 1):128-40 23175362 - J Virol. 2013 Feb;87(3):1290-300 23635778 - J Clin Invest. 2013 Jun;123(6):2629-42 20656034 - Vaccine. 2010 Aug 31;28(38):6176-82 16054263 - J Control Release. 2005 Sep 20;107(1):1-29 25273353 - Gene Ther. 2015 Jan;22(1):76-86 25505299 - J Infect Dis. 2015 Jun 1;211(11):1831-41 21592111 - Clin Exp Immunol. 2011 Aug;165(2):180-9 24715281 - Methods Mol Biol. 2014;1143:33-59 25263172 - Trends Mol Med. 2014 Nov;20(11):604-13 22437871 - Nat Rev Cancer. 2012 Mar 22;12(4):265-77 21253784 - Curr Top Microbiol Immunol. 2012;351:113-38 16143986 - Eur J Immunol. 2005 Oct;35(10 ):2815-25 22821982 - Science. 2012 Aug 31;337(6098):1111-5 23874462 - PLoS One. 2013 Jul 09;8(7):e67888 23633407 - J Infect Dis. 2013 Aug 1;208(3):418-22 19249301 - Exp Parasitol. 2009 Jun;122(2):112-23 20483769 - J Immunol. 2010 Jun 15;184(12):7100-7 25953029 - Immunol Cell Biol. 2015 Nov;93(10 ):868-76 11739689 - J Virol. 2002 Jan;76(1):243-50 21536790 - Infect Immun. 2011 Jul;79(7):2819-28 20877623 - PLoS One. 2010 Sep 21;5(9):e12873 21107437 - Gene Ther. 2011 Apr;18(4):372-83 24690150 - Vaccine. 2014 May 23;32(25):3058-65 8456302 - Science. 1993 Mar 19;259(5102):1745-9 22309668 - Expert Rev Vaccines. 2012 Feb;11(2):189-209 16140431 - Vaccine. 2006 May 22;24(21):4531-40 22768853 - Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2012 Jul;28(7):680-3 23689601 - Mol Ther. 2013 Aug;21(8):1526-35 15906276 - Rev Med Virol. 2005 Sep-Oct;15(5):303-25 23633404 - J Infect Dis. 2013 Aug 1;208(3):413-7 23577062 - PLoS One. 2013;8(4):e59340 23624057 - Vaccine. 2013 Aug 12;31(36):3747-55 21677141 - J Immunol. 2011 Jul 15;187(2):842-50 15297060 - Vaccine. 2004 Aug 13;22(23-24):3092-7 21892174 - Nat Immunol. 2011 Sep 04;12(10):959-65 23796714 - Semin Immunol. 2013 Oct 31;25(3):209-18 |
| References_xml | – reference: 23371516 - Pharm Res. 2013 Jun;30(6):1502-12 – reference: 25104313 - BMC Bioinformatics. 2014;15 Suppl 4:S2 – reference: 22437871 - Nat Rev Cancer. 2012 Mar 22;12(4):265-77 – reference: 11130078 - Nature. 2000 Dec 7;408(6813):740-5 – reference: 22095092 - Cancer Immunol Immunother. 2012 Jun;61(6):893-903 – reference: 23689601 - Mol Ther. 2013 Aug;21(8):1526-35 – reference: 23796714 - Semin Immunol. 2013 Oct 31;25(3):209-18 – reference: 23633404 - J Infect Dis. 2013 Aug 1;208(3):413-7 – reference: 25539925 - Nucleic Acids Res. 2015 Mar 11;43(5):e34 – reference: 9013964 - J Immunol. 1997 Feb 1;158(3):1231-7 – reference: 23746241 - Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2013 Jun;29(6):585-8 – reference: 19389445 - Vaccine. 2009 Jun 19;27(30):4010-7 – reference: 16965361 - FEMS Immunol Med Microbiol. 2006 Oct;48(1):132-9 – reference: 21371510 - J Control Release. 2011 Jun 30;152(3):349-55 – reference: 24648995 - Biomed Rep. 2013 Jul;1(4):609-613 – reference: 25984993 - Hum Vaccin Immunother. 2015;11(8):1889-900 – reference: 21152572 - Mol Biosyst. 2011 Mar;7(3):809-16 – reference: 19321146 - Curr Biol. 2009 Mar 24;19(6):R262-5 – reference: 21765404 - Nat Med. 2011 Jul 17;17 (8):996-1002 – reference: 22821982 - Science. 2012 Aug 31;337(6098):1111-5 – reference: 23633407 - J Infect Dis. 2013 Aug 1;208(3):418-22 – reference: 24932692 - PLoS One. 2014 Jun 16;9(6):e99887 – reference: 19249301 - Exp Parasitol. 2009 Jun;122(2):112-23 – reference: 25746201 - Hum Vaccin Immunother. 2015;11(8):1983-90 – reference: 21931737 - PLoS One. 2011;6(9):e24517 – reference: 23488597 - J Fish Dis. 2013 Sep;36(9):763-8 – reference: 8506285 - Proc Natl Acad Sci U S A. 1993 May 15;90(10):4455-9 – reference: 26344618 - Vaccines (Basel). 2014 Mar 25;2(2):196-215 – reference: 23861017 - Virus Genes. 2013 Oct;47(2):259-67 – reference: 24316385 - J Theor Biol. 2014 Mar 7;344:19-30 – reference: 23647843 - Cell. 2013 May 23;153(5):1094-107 – reference: 16601357 - Intervirology. 2006;49(4):249-52 – reference: 25270431 - Eur J Immunol. 2015 Jan;45(1):82-8 – reference: 21107437 - Gene Ther. 2011 Apr;18(4):372-83 – reference: 1545867 - Nature. 1992 Mar 12;356(6365):152-4 – reference: 23196205 - Vaccine. 2013 Jan 11;31(4):676-84 – reference: 21844392 - J Immunol. 2011 Sep 15;187(6):3391-401 – reference: 9795388 - Vaccine. 1998 Nov;16(19):1828-35 – reference: 23774102 - J Control Release. 2013 Sep 28;170(3):452-9 – reference: 21772284 - Nat Immunol. 2011 Jul 19;12(8):729-31 – reference: 24690150 - Vaccine. 2014 May 23;32(25):3058-65 – reference: 18256672 - Nature. 2008 Feb 7;451(7179):725-9 – reference: 23709057 - Virol Sin. 2013 Jun;28(3):167-73 – reference: 23251783 - Elife. 2012 Dec 18;1:e00047 – reference: 20656034 - Vaccine. 2010 Aug 31;28(38):6176-82 – reference: 16490926 - Microbiol Immunol. 2006;50(2):83-92 – reference: 24448159 - Parasitol Int. 2014 Apr;63(2):408-16 – reference: 11039923 - Science. 2000 Oct 20;290(5491):486-92 – reference: 12390544 - J Med Primatol. 2002 Aug;31(4-5):217-27 – reference: 23841051 - Biomed Res Int. 2013;2013:136492 – reference: 8456302 - Science. 1993 Mar 19;259(5102):1745-9 – reference: 23151452 - Hum Vaccin Immunother. 2012 Nov 1;8(11):1659-67 – reference: 20351693 - Nat Immunol. 2010 May;11(5):385-93 – reference: 24447183 - Clin Microbiol Infect. 2014 May;20 Suppl 5:110-7 – reference: 21975270 - Lancet Infect Dis. 2011 Dec;11(12):916-24 – reference: 1690918 - Science. 1990 Mar 23;247(4949 Pt 1):1465-8 – reference: 23270684 - Mol Immunol. 2013 Jun;54(2):109-14 – reference: 25273353 - Gene Ther. 2015 Jan;22(1):76-86 – reference: 16054263 - J Control Release. 2005 Sep 20;107(1):1-29 – reference: 23624057 - Vaccine. 2013 Aug 12;31(36):3747-55 – reference: 10946143 - Vet Microbiol. 2000 Sep 25;76(2):129-42 – reference: 21536790 - Infect Immun. 2011 Jul;79(7):2819-28 – reference: 23258413 - Science. 2013 Feb 15;339(6121):786-91 – reference: 24284319 - J Virol. 2014 Feb;88(4):1924-34 – reference: 20483191 - Vaccine. 2010 Jul 19;28(32):5347-55 – reference: 8399489 - Hum Gene Ther. 1993 Aug;4(4):419-31 – reference: 9820537 - J Immunol. 1998 Nov 15;161(10):5594-9 – reference: 16525482 - Gene Ther. 2006 Jul;13(14):1110-7 – reference: 24385146 - Gene Ther. 2014 Feb;21(2):225-32 – reference: 15906276 - Rev Med Virol. 2005 Sep-Oct;15(5):303-25 – reference: 23840043 - J Infect Dis. 2013 Sep 1;208(5):818-29 – reference: 25070851 - J Immunol. 2014 Sep 1;193(5):2394-404 – reference: 21198665 - Immunol Rev. 2011 Jan;239(1):62-84 – reference: 20890285 - Nat Immunol. 2010 Nov;11(11):997-1004 – reference: 23036592 - J Neuroimmunol. 2013 Jan 15;254(1-2):63-8 – reference: 18781156 - Nat Rev Genet. 2008 Oct;9(10):776-88 – reference: 21987727 - Cancer Res. 2011 Dec 15;71(24):7452-62 – reference: 25505299 - J Infect Dis. 2015 Jun 1;211(11):1831-41 – reference: 21169215 - J Gen Virol. 2011 Jan;92(Pt 1):128-40 – reference: 15479434 - Immunol Cell Biol. 2004 Oct;82(5):488-96 – reference: 25265876 - Med Microbiol Immunol. 2015 Aug;204(4):481-91 – reference: 23175362 - J Virol. 2013 Feb;87(3):1290-300 – reference: 16226783 - Virology. 2006 Jan 20;344(2):412-20 – reference: 21743478 - Nat Immunol. 2011 Jul 10;12(8):786-95 – reference: 16179799 - J Mol Microbiol Biotechnol. 2004;8(4):222-31 – reference: 19579009 - Biotechnol Lett. 2009 Nov;31(11):1685-93 – reference: 23941509 - BMC Immunol. 2013 Aug 14;14:39 – reference: 24830435 - Gene Ther. 2014 Jul;21(7):703-8 – reference: 22768853 - Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2012 Jul;28(7):680-3 – reference: 15068842 - Vaccine. 2004 Apr 16;22(13-14):1609-15 – reference: 21253784 - Curr Top Microbiol Immunol. 2012;351:113-38 – reference: 23227156 - PLoS One. 2012;7(12):e49952 – reference: 26121679 - PLoS One. 2015 Jun 29;10(6):e0131748 – reference: 10048771 - J Interferon Cytokine Res. 1999 Jan;19(1):77-84 – reference: 24884387 - Respir Res. 2014 May 20;15:60 – reference: 9712056 - J Immunol. 1998 Aug 15;161(4):1875-82 – reference: 21573215 - PLoS One. 2011 May 05;6(5):e19407 – reference: 24828254 - Curr Gene Ther. 2014;14(3):161-9 – reference: 22361816 - Cancer Gene Ther. 2012 May;19(5):303-11 – reference: 20877623 - PLoS One. 2010 Sep 21;5(9):e12873 – reference: 22552442 - Mol Med Rep. 2012 Jul;6(1):139-44 – reference: 21157438 - Mol Ther. 2011 Mar;19(3):594-601 – reference: 23631937 - Virus Res. 2013 Aug;175(2):120-7 – reference: 24821782 - Proc Natl Acad Sci U S A. 2014 May 27;111(21):7747-52 – reference: 22309668 - Expert Rev Vaccines. 2012 Feb;11(2):189-209 – reference: 21815811 - OMICS. 2011 Sep;15(9):533-7 – reference: 10501231 - Vaccine. 1999 Aug 20;18(1-2):18-28 – reference: 23457473 - PLoS One. 2013;8(2):e55571 – reference: 25142448 - Curr Gene Ther. 2014;14(3):170-89 – reference: 25487734 - Expert Rev Vaccines. 2015 Feb;14(2):195-204 – reference: 25488991 - J Immunol. 2015 Jan 15;194(2):630-6 – reference: 20833440 - Trends Biotechnol. 2010 Nov;28(11):570-9 – reference: 22133510 - Vaccine. 2012 Jan 17;30(4):758-66 – reference: 23388631 - Proc Natl Acad Sci U S A. 2013 Feb 19;110(8):2969-74 – reference: 23776192 - J Infect Dis. 2013 Sep;208(6):1008-19 – reference: 23111169 - Hum Vaccin Immunother. 2012 Nov 1;8(11):1654-8 – reference: 20483769 - J Immunol. 2010 Jun 15;184(12):7100-7 – reference: 23874462 - PLoS One. 2013 Jul 09;8(7):e67888 – reference: 21677141 - J Immunol. 2011 Jul 15;187(2):842-50 – reference: 21544098 - Gene Ther. 2012 Jan;19(1):70-7 – reference: 22806099 - Mucosal Immunol. 2013 Jan;6(1):156-66 – reference: 24440303 - Int Immunopharmacol. 2014 Mar;19(1):74-80 – reference: 21107439 - Gene Ther. 2011 Apr;18(4):334-43 – reference: 21857901 - PLoS One. 2011;6(8):e21225 – reference: 20432465 - J Cell Physiol. 2010 Sep;224(3):702-9 – reference: 8212843 - Vaccine. 1993;11(9):957-60 – reference: 21892174 - Nat Immunol. 2011 Sep 04;12(10):959-65 – reference: 22350714 - Parasitol Res. 2012 Jul;111(1):403-11 – reference: 15312142 - Immunology. 2004 Sep;113(1):114-20 – reference: 17618271 - Nature. 2007 Jul 26;448(7152):501-5 – reference: 23635778 - J Clin Invest. 2013 Jun;123(6):2629-42 – reference: 25263172 - Trends Mol Med. 2014 Nov;20(11):604-13 – reference: 25410055 - Eur J Immunol. 2015 Feb;45(2):624-35 – reference: 21325489 - Clin Vaccine Immunol. 2011 Apr;18(4):533-8 – reference: 19237523 - Infect Immun. 2009 May;77(5):2221-9 – reference: 11739689 - J Virol. 2002 Jan;76(1):243-50 – reference: 21732819 - OMICS. 2011 Sep;15(9):625-36 – reference: 24788626 - PLoS One. 2014 May 01;9(5):e96609 – reference: 15297060 - Vaccine. 2004 Aug 13;22(23-24):3092-7 – reference: 18694965 - Infect Immun. 2008 Oct;76(10):4564-73 – reference: 25953029 - Immunol Cell Biol. 2015 Nov;93(10 ):868-76 – reference: 23228812 - Vaccine. 2013 Jan 21;31(5):784-90 – reference: 12477432 - Vaccine. 2002 Dec 19;20 Suppl 4:A69-79 – reference: 25192845 - BMC Infect Dis. 2014 Sep 06;14:487 – reference: 21592111 - Clin Exp Immunol. 2011 Aug;165(2):180-9 – reference: 25364509 - Ther Adv Vaccines. 2014 Nov;2(6):159-82 – reference: 24573220 - Arch Virol. 2014 Aug;159(8):1951-60 – reference: 19066740 - Immunol Res. 2008;42(1-3):219-32 – reference: 24694539 - Gene Ther. 2014 Jun;21(6):566-74 – reference: 19162111 - Vaccine. 2009 Feb 25;27(9):1306-16 – reference: 21102455 - Nat Biotechnol. 2010 Dec;28(12):1287-9 – reference: 25027602 - Cytokine Growth Factor Rev. 2014 Dec;25(6):649-55 – reference: 25992460 - J Biomed Nanotechnol. 2014 Sep;10(9):2332-49 – reference: 20583863 - Hum Gene Ther. 2010 Dec;21(12):1687-96 – reference: 24720881 - Biomaterials. 2014 Jul;35(21):5491-504 – reference: 22930438 - J Gene Med. 2012 Sep-Oct;14(9-10):563-9 – reference: 24968881 - Oncology. 2014;87(1):21-9 – reference: 24631071 - Vaccine. 2014 Apr 25;32(20):2308-14 – reference: 23459514 - Mol Ther. 2013 May;21(5):954-63 – reference: 24531764 - Nature. 2014 Mar 27;507(7493):519-22 – reference: 24812879 - Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2013 Aug;31(4):284-9 – reference: 16143986 - Eur J Immunol. 2005 Oct;35(10 ):2815-25 – reference: 22240344 - Vaccine. 2012 Feb 21;30(9):1624-35 – reference: 23577062 - PLoS One. 2013;8(4):e59340 – reference: 23142775 - Nat Immunol. 2012 Dec;13(12):1155-61 – reference: 15652668 - Vaccine. 2005 Jan 26;23(10):1258-64 – reference: 15491818 - J Control Release. 2004 Nov 5;100(1):145-55 – reference: 16140431 - Vaccine. 2006 May 22;24(21):4531-40 – reference: 26122168 - Drug Deliv Transl Res. 2015 Aug;5(4):424-37 – reference: 24717539 - Nat Commun. 2014 Apr 10;5:3566 – reference: 21106745 - J Virol. 2011 Feb;85(3):1370-83 – reference: 20371391 - Vaccine. 2010 May 21;28(23):3888-95 – reference: 24122866 - J Med Virol. 2014 May;86(5):886-94 – reference: 21081900 - Mol Ther. 2011 Mar;19(3):450-60 – reference: 24715281 - Methods Mol Biol. 2014;1143:33-59 – reference: 25128840 - Immunol Lett. 2014 Nov;162(1 Pt A):140-8 |
| SSID | ssj0034957 |
| Score | 2.5542243 |
| SecondaryResourceType | review_article |
| Snippet | In the two decades since their initial discovery, DNA vaccines technologies have come a long way. Unfortunately, when applied to human subjects inadequate... |
| SourceID | pubmed |
| SourceType | Index Database |
| StartPage | 313 |
| SubjectTerms | Animals Humans Vaccination - methods Vaccines, DNA - administration & dosage Vaccines, DNA - immunology |
| Title | Molecular mechanisms for enhanced DNA vaccine immunogenicity |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/26707950 |
| Volume | 15 |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ1ZS8NAEMcXDwRfxPuWPPhWojn2SMCX4oGI7ZOFvpXdzQSDtBUNgn56Z7ObNvVCfQklS5a0v-x0Zyb_GUKO80wqYHHq6xA4Oigp85NECR94boSfeQJgQgOdLr_u0Zs-69fd7J26pFQn-u1LXcl_qOI55GpUsn8gO5kUT-Bn5ItHJIzHXzHu1L1tW0MwCt7i2ZZXaMHo3mb2L7rt1ovUJnveKowUZIyTFbooZ7K5Vb3jsiFjcZdM9tu3VkMNxdSSlk_jFxd47RYP6CAXzQBCyKs3qKxRAWv0BKU-bpTYjFVkDfpxw8TFVjv6yfSyKhMUUmESrSZaFXKjT6LO2jZwPA4rHhE31fls2dmfRz9UxK6H5sk8-gam2amJ0Nh_3xgdPuGUWnhHp1_ej6kA7eb44E1Uu4q7VbLi3AGvbdmukTkYrZMl2yD0dYOcTQh7U8IeEvZqwh4S9hwub5bwJuldXd6dX_uu34WveUBLX-RRKiRkSmQiUZBlEdUK9-sZ14FQOUtkrCCVIANq3huI80DiMhOBzhmTnMXRFlkYjUewQzxT1ieKcOXJVNMwoykPOVeJALToKon0Ltm2X3vwaIuaDOofZO_bkX2yPH18DshijqsIDnFLVqqjisE7Nvsyow |
| linkProvider | National Library of Medicine |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Molecular+mechanisms+for+enhanced+DNA+vaccine+immunogenicity&rft.jtitle=Expert+review+of+vaccines&rft.au=Li%2C+Lei&rft.au=Petrovsky%2C+Nikolai&rft.date=2016-03-03&rft.eissn=1744-8395&rft.volume=15&rft.issue=3&rft.spage=313&rft_id=info:doi/10.1586%2F14760584.2016.1124762&rft_id=info%3Apmid%2F26707950&rft_id=info%3Apmid%2F26707950&rft.externalDocID=26707950 |